CMS Proposed Rule Locks in Lower Prices and Fosters Innovation for the Medicare Drug Price Negotiation Program
By
Fri, 06/12/2026 - 16:19
Source
cms.govCMS Proposed Rule Locks in Lower Prices and Fosters Innovation for the Medicare Drug Price Negotiation Programcms.govYou might also wanna read
Research Reveals Persistent Drug Pricing Distortions from PBM-Owned Pharmaceutical Companies
The article examines the persistent distortions in U.S. drug pricing, particularly focusing on vertically integrated pharmacy benefit manage
46brooklyn.com·7mo ago
CMS launches ACCESS 10-year pilot to expand tech-enabled chronic care in Original Medicare
CMS announced the ACCESS model, a nationwide, voluntary 10-year pilot program starting July 5, 2026, that tests outcome-aligned payments and
How Pricing Algorithms Can Lead to Higher Prices Through Algorithmic Collusion
The article explores how pricing algorithms, even simple ones, can lead to higher consumer prices through algorithmic collusion without expl
quantamagazine.org·8mo ago
TERMS-Bench: A New Diagnostic Framework for Evaluating LLM Negotiation Agents Beyond Deal Rate
This article introduces TERMS-Bench (Testbed for Economic Reasoning in Multi-turn Strategy), a new evaluation framework for diagnosing LLM n
arxiv.org·17d ago
Healthcare Providers Face Paradigm Shift as Patients Increasingly Use AI Chatbots and Health Apps
Healthcare providers are facing a significant shift as patients increasingly turn to AI chatbots and health apps for medical advice and care
twp.ai·14d ago
Drugmakers Plan Price Increases on 350+ Medications Despite Government Pressure
Drugmakers plan to raise U.S. prices on at least 350 branded medications in 2026, including COVID, RSV, and shingles vaccines, as well as ca
reuters.com·6mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.